U.S. market Closed. Opens in 5 hours 10 minutes

TRVI | Trevi Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
RevenueN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue123.00K43.00K50.00K47.00K39.00KN/AN/A
Gross Profit-123.00K-43.00K-50.00K-47.00K-39.00KN/AN/A
Operating Expenses33.92M29.91M32.48M32.49M26.64M18.41M8.24M
Selling, General & Admin10.24M10.07M9.49M10.16M7.31M4.34M2.14M
Research & Development23.68M19.83M22.98M22.33M19.34M14.07M6.09M
Other Operating ExpensesN/A719.00K-375.00K-287.00K577.00K-2.24MN/A
Operating Income-33.92M-29.91M-32.48M-32.49M-26.64M-18.41M-8.24M
Other Expenses / Income4.83M719.00K-1.49M-287.00K577.00K-2.24M-4.65M
Before Tax Income-29.10M-29.19M-33.96M-32.78M-26.07M-20.67M-12.89M
Income Tax Expenses32.00K-36.00K-21.00K-18.00K-18.00K-124.00K-26.00K
Net Income-29.07M-29.15M-33.94M-32.76M-26.05M-20.55M-12.86M
Interest Expenses391.00K780.00K1.20M456.00KN/A174.00K3.34M
Basic Shares Outstanding99.03M64.54M22.84M18.06M11.74M8.97M8.97M
Diluted Shares Outstanding99.03M64.54M22.84M18.06M11.74M8.97M8.97M
EBITDA-33.80M-29.91M-32.79M-32.49M-26.64M-20.47M-9.54M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-28.64M-28.41M-32.76M-32.32M-26.07M-20.50M-9.54M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙